Healthcare deals are (sort of) back: What healthcare investment in 2025 tells us about the broader healthcare market
Explore the resurgence of healthcare investment in 2025 and its impact on the broader market. Discover what's next for healthcare investment in 2026.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
After a couple of uneven years, healthcare dealmaking came back to life in 2025. By most measures, both deal volume and value are trending upward again—though still off the torrid pace of 2021, when cheap capital and a post‑pandemic spending spree sent valuations through the roof.
At Union, we tend to read deal activity as one of the better directional cues for where healthcare is headed. When capital flows change course, market strategy usually isn’t far behind. And while the rebound is real, the tone of the market feels different this time around—less speculative, more disciplined.
In this blog post, we’ll cover:
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
The new patient financial reality
The Great Utilization Shift
How one health system is creatively pushing back against a labor squeeze